Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Intraday Session

 

Gainers

  • Longeveron (NASDAQ:LGVN) stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million shares, making up 8203.2% of its average full-day volume over the last 100 days. The company's market cap stands at $225.6 million.
  • Clovis Oncology (NASDAQ:CLVS) stock increased by 53.03% to $2.52. The current volume of 164.6 million shares is 3327.9% of Clovis Oncology's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $359.1 million.
  • SAB Biotherapeutics (NASDAQ:SABS) stock rose 37.3% to $3.57. Trading volume for SAB Biotherapeutics's stock is 1.5 million as of 13:31 EST. This is 1521.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $153.3 million. As per the press release, Q4 earnings came out 2 days ago.
  • Icosavax (NASDAQ:ICVX) stock moved upwards by 28.51% to $6.85. Trading volume for Icosavax's stock is 3.2 million as of 13:31 EST. This is 1254.0% of its average full-day volume over the last 100 days. The company's market cap stands at $267.4 million. The company's, Q4 earnings came out yesterday.
  • Trevena (NASDAQ:TRVN) shares increased by 22.43% to $0.54. As of 13:31 EST, this security is trading at a volume of 8.8 million shares, making up 1148.3% of its average full-day volume over the last 100 days. The company's market cap stands at $88.8 million. As per the news, the Q4 earnings report came out today.
  • Creative Medical Tech (NASDAQ:CELZ) stock increased by 18.28% to $4.01. As of 13:31 EST, Creative Medical Tech's stock is trading at a volume of 17.6 million, which is 321.2% of its average full-day volume over the last 100 days. The company's market cap stands at $25.3 million. As per the news, the Q4 earnings report came out yesterday.

 

Losers

  • Acutus Medical (NASDAQ:AFIB) stock declined by 24.4% to $1.46 during Thursday's regular session. Trading volume for Acutus Medical's stock is 520.3K as of 13:31 EST. This is 103.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.8 million. As per the press release, Q4 earnings came out yesterday.
  • Hillstream BioPharma (NASDAQ:HILS) stock fell 23.65% to $1.55. Trading volume for this security as of 13:31 EST is 910.7K, which is 126.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.4 million.
  • Sharecare (NASDAQ:SHCR) shares declined by 18.34% to $2.69. As of 13:31 EST, this security is trading at a volume of 2.4 million shares, making up 167.5% of its average full-day volume over the last 100 days. The company's market cap stands at $913.6 million. As per the news, the Q4 earnings report came out today.
  • NRX Pharmaceuticals (NASDAQ:NRXP) stock declined by 17.02% to $2.37. The current volume of 1.6 million shares is 189.2% of NRX Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $157.5 million. The company's, Q4 earnings came out today.
  • Vyant Bio (NASDAQ:VYNT) shares declined by 16.46% to $1.34. Trading volume for Vyant Bio's stock is 1.2 million as of 13:31 EST. This is 274.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.9 million. As per the press release, Q4 earnings came out yesterday.
  • OncoSec Medical (NASDAQ:ONCS) stock decreased by 15.95% to $1.16. OncoSec Medical's stock is trading at a volume of 390.6K shares as of 13:31 EST. This is 302.1% of its average full-day volume over the last 100 days. The company's market cap stands at $45.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.